Trials that use: Covariate adjustment
5,848 results
- RESCUE Study – Everolimus in Liver Transplantation Recipients With Renal Insufficiency: Complete Statistical AnalysisIndependent statistical analysis of RESCUE Study - Everolimus in Liver Transplantation Recipients With Renal Insufficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Research Study to Determine Sensitivity to Gentle Touch and Pressure During an Active Migraine Attack.: Complete Statistical AnalysisIndependent statistical analysis of Research Study to Determine Sensitivity to Gentle Touch and Pressure During an Active Migraine Attack.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin: Complete Statistical AnalysisIndependent statistical analysis of Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03296033).
- Residual Gastric Volume Measured by Ultrasound in Diabetic Surgical Population Versus Non-diabetic Surgical Population.: Complete Statistical AnalysisIndependent statistical analysis of Residual Gastric Volume Measured by Ultrasound in Diabetic Surgical Population Versus Non-diabetic Surgical Population.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RESISTIndependent statistical analysis of Aspirin Resistance and Percutaneous Coronary Intervention (PCI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01103440).
- RESOLVEIndependent statistical analysis of Tailored Non-Pharmacotherapy Services for Chronic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04523714).
- Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00400153).
- Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017): Complete Statistical AnalysisIndependent statistical analysis of Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RESPIRE 1Independent statistical analysis of RESPIRE 1, a randomized phase 3 trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis, including time-to-exacerbation and exacerbation-rate analyses.
- RESPIRE 1Independent statistical analysis of Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.: Complete Statistical AnalysisIndependent statistical analysis of Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Responses to Message Source and Presentation Using Psychophysiology: Complete Statistical AnalysisIndependent statistical analysis of Responses to Message Source and Presentation Using Psychophysiology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06269003).
- Responses to Rabies Vaccine in Adults With or Without Antibiotics: Complete Statistical AnalysisIndependent statistical analysis of Responses to Rabies Vaccine in Adults With or Without Antibiotics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03557008).
- REST-ITIndependent statistical analysis of Reducing Suicidal Ideation Through Insomnia Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01689909).
- Restasis for Treatment of Brittle Nails: Complete Statistical AnalysisIndependent statistical analysis of Restasis for Treatment of Brittle Nails: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00986427).
- RESTOREIndependent statistical analysis of A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ReSTOREIndependent statistical analysis of Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RESTORE-MEIndependent statistical analysis of Effects of a Resistance Training Program in Older Women With Sarcopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE): Complete Statistical AnalysisIndependent statistical analysis of REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00271154).
- Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus: Complete Statistical AnalysisIndependent statistical analysis of Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00539994).
- RETHINCIndependent statistical analysis of RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials Cooperative: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ReTHINKIndependent statistical analysis of Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations.: primary endpoint results, effect estimate with confidence interval, sample-size…
- Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Retrospective Evaluation of Performance of Coflex® Interlaminer Technology Versus Decompression With or Without Fusion: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Evaluation of Performance of Coflex® Interlaminer Technology Versus Decompression With or Without Fusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RetroTIFIndependent statistical analysis of Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Return of First-phase Insulin Secretion in Type 2 Diabetes is Associated With Depletion of Pancreas Lipid: Complete Statistical AnalysisIndependent statistical analysis of Return of First-phase Insulin Secretion in Type 2 Diabetes is Associated With Depletion of Pancreas Lipid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- REVEALIndependent statistical analysis of REVEAL III: Risk Evaluation and Education for Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00462917).
- REVEALIndependent statistical analysis of REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01252953).
- REVEAL 1Independent statistical analysis of REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04169529).
- Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib: Complete Statistical AnalysisIndependent statistical analysis of Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01466972).
- Reversing Synchronized Brain Circuits With Targeted Auditory-Somatosensory Stimulation to Treat Phantom Percepts: Complete Statistical AnalysisIndependent statistical analysis of Reversing Synchronized Brain Circuits With Targeted Auditory-Somatosensory Stimulation to Treat Phantom Percepts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01600053).
- Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic: Complete Statistical AnalysisIndependent statistical analysis of Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RHA® Redensity Eye Versus No-treatment for the Infra-Orbital Hollows: Complete Statistical AnalysisIndependent statistical analysis of RHA® Redensity Eye Versus No-treatment for the Infra-Orbital Hollows: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04577898).
- RHINEIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Rhythm-based Intervention in Aphasia: Complete Statistical AnalysisIndependent statistical analysis of Rhythm-based Intervention in Aphasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04581564).
- Ri-CoDIFy 3Independent statistical analysis of Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04802837).
- Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RIGHT: Rhythm ID Going Head-to-Head Trial: Complete Statistical AnalysisIndependent statistical analysis of RIGHT: Rhythm ID Going Head-to-Head Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00148954).
- RILECSUIndependent statistical analysis of Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine: primary endpoint results, effect estimate with confidence interval, sample-size…
- Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00523718).
- RIPCOM1Independent statistical analysis of The Right Ventricular Pulmonary Circulation Continuum in Mitral Valve Disease Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RISE AdultIndependent statistical analysis of RISE Adult Medication Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01779362).
- RISE+Independent statistical analysis of Testing the Efficacy and Mechanisms of an Adapted Resilience Building Intervention in People Aging With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening: Complete Statistical AnalysisIndependent statistical analysis of Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar: Complete Statistical AnalysisIndependent statistical analysis of Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00176202).
- Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval,…